Dr. D. Lansing Taylor is the Director at the University of Pittsburgh Drug Discovery Institute and an expert on Computational Biology. He has translated that expertise into more than 29 patents and multiple successful startups

 

His companies include Biological Detection Systems (now owned by GE Life Sciences), Cellomics (acquired by ThermoFisher), and Cellumen (now part of Cyprotex).

 

Dr. Taylor’s current companies are Spintellx and BioSystics. Spintellx focuses on computational pathology, using machine learning to identify abnormalities in tissue samples. BioSystics is a database and analytics firm that creates digital twins from complex data for research institutions and Big Pharma clients.

 

In this episode, Dr. Taylor and Aaron discuss the potential of precision medicine, the application of digital twins, and how doctors will work with data in the future.

Connect with Dr. D. Lansing Taylor

Linkedin

Facebook

Website

 

If you liked this interview, check out Building a Billion Dollar Company Treating Rare Diseases w/ Dr Gordon Vanscoy

 

Underwritten by Piper Creative

Piper Creative makes creating podcasts, vlogs, and videos easy. 

 

How? Click here and Learn more.

 

We work with Fortune 500s, medium-sized companies, and entrepreneurs.

 

Follow Piper as we grow

YouTube

 

Subscribe on iTunes | Stitcher | Overcast | Spotify